CARPINTERIA, Calif.--(BUSINESS WIRE)--Based on a strategy to deliver a broad range of assays for use on the Celerus Wave® System, Jason Lusk, Vice President of Sales and Marketing, today announced the availability of Wave Direct Immunofluorescence (IF).
